PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.235
-0.055 (-4.26%)
Aug 1, 2025, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 853.19 million as of August 1, 2025. Its market cap has decreased by -48.71% in one year.
Market Cap
853.19M
Enterprise Value
839.93M
Revenue
115.58M
Ranking
n/a
PE Ratio
147.06
Stock Price
1.24
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 853.19M, an increase of 2,478.62%. That is a compound annual growth rate of 13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 853.19M | -39.46% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | 2.57B | 96.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.69B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |